In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

When psoriasis develops on your feet, it can cause uncomfortable itching or soreness that makes tasks like walking difficult. Psoriasis, an autoimmune skin condition, usually causes scaly rashes ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Until about ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

Psoriasis and psoriatic arthritis (PsA) are both psoriatic diseases, which means they are related. Psoriasis increases your risk of PsA, but this doesn't mean you will get it. While there's no ...

BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523 ...